Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences / biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
Using our distribution capabilities, we target a specific group of investors and organize meetings that can maximize management’s time. In our experience, an orchestrated process helps to streamline the transaction and thereby its competitiveness. A key to our success is aligning ourselves with top investors, strategic thinkers, entrepreneurs and executives around the world.
Latest Maxim Group News
WiSA Technologies, Inc. (Nasdaq: WISA), a developer of spatial, wireless sound technology for smart devices
CorpHousing Group Inc. (“CorpHousing” or the “Company”) (Nasdaq: CHG), a company engaged in the short-term rental of
Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in